Vancouver, BC – TheNewswire - November 26, 2024 – Pegasus Mercantile Inc. (formerly Xtacy Therapeutics Corp.) (CSE: LOAN) (Frankfurt: U04) (OTC: XTCYF) (“the Company) provides business updates and announces the formation of new Business Units and the addition of 2 Key Team Members.

The Company is pleased to announce the creation of two 100% wholy owned subsidiaries, a pharma, health and wellness one and a seperate beverage business unit.

Biomed International Inc. will be the wholly owned pharma subsidiary. Pegasus intends to announce a capital raise up to $10 million shortly to support the projects within the new subsidiary after obtaining regulatory approvals.  The team of Biomed360 Solutions Corp., BM360, a medical advisor of the Company since November 2022, will lead this business unit. Since 2019, BM360 has been focused on identifying cutting edge biotech and medical technology platform solutions within the medical and pharmaceutical industries. Most recently, BM360 is engaging with clinical stage biotechnology companies entering human clinical trials for various diseases including diabetes and forms of cancer. The Company has been collaborating with BM360 and AVM Biotechnology since announcing their efforts in 2022. AVM Biotechnology is developing and advancing a proprietary formulation of its unique molecule AVM0703. This formulation permits the very high dosing necessary to activate the release and trigger the production of the body’s supercharged gamma delta+ Natural Killer T-like (AVM-NKT) immune cells. These cells have unique immune response properties in comparison to ordinary T-cells and rapidly appear following a single AVM0703 dose. Pre-clinical and early clinical data indicate that these cells could play a significant role in several diseases and conditions.

The second subsidiary, Bevteck International Inc. will focus on developing and distributing beverages, alcoholic and non-alcoholic including water and health and wellness beverages. The Company recently signed an Advisory Agreement with British Columbia based Bevteck Industries Inc. a production and canning facility, distributing alcoholic and non-alcoholic beverages, with an expanding portfolio and plans to enter new global markets. Their mission is to develop beverage brands that offer a strong value proposition for the consumer and fill needs and gaps in the marketplace. Bevteck currently produces wines, waters, coffee drinks and healthy craft-formulated drinks in their bottling plant. Pegasus plans to help finance the future growth of Bevteck and the beverage business unit with a raise up to $2 million after regulatory approvals are obtained.

New Director and Advisor:

On October 8th, the Company announced the appointment of Vanni Barbon  a seasoned banker and capital markets executive, as a Director and the new Audit Chair.

Additionally, the Company is pleased to announce Dan Lauzon as a new advisor to our Medical Advisory team. Mr. Lauzon is a prominent business leader from Cornwall, Ontario, known for his significant contributions to the health and wellness industry as the Chief Business Development Officer at Ideal Protein and for his entrepreneurial endeavors. He is also the founder of ADMSGlobal.com, a global platform that offers Augmented Intelligence for integrated siloed businesses, allowing for compatibility between these silos while utilizing AI and navigating big data-rich environments.

« The Company continues to seek business opportunities with high growth potential where Pegasus can provide strategic advice and participation to maximize profit potential in the current competitive environment. New projects, alternative business units, new key team members will all help build Pegasus as a leader in the health and wellness sector. We wish all our shareholders. clients and supporters safe travels and happy holidays,» Meris Kott, CEO, Pegasus Mercantile Inc.  

About Pegasus Mercantile:

Pegasus is a prospect generator that provides high growth companies with financial, operational, and management assistance in the fast growing market for wellness consumer products. The focus of the Company is on global wellness, psychedelics, mycology, hemp and CBD, healthcare-related target companies and their clinical studies and trials.

For further information visit website:

 www.pegasusmercantile.com Contact Meris Kott CEO info@pegasusmercantile.com (561) 212-3323

Further information about the Company is available on www.SEDARplus.com under the Company’s profile.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.